XML 54 R42.htm IDEA: XBRL DOCUMENT v3.23.1

SEGMENT AND ENTERPRISE-WIDE INFORMATION (Tables)

12 Months Ended

Apr. 01, 2023

Segment Reporting [Abstract]

Selected Information by Business Segment

(In thousands)			2023						2022						2021
Net revenues
Plasma			$	500,489					$	351,945					$	333,334
Blood Center			289,365						294,541						307,370
Hospital			378,206						321,580						210,606
Net revenues by business unit			1,168,060						968,066						851,310
Service (1)			21,424						20,811						20,758
Effect of exchange rates			(20,824)						4,319						(1,605)
Net revenues			$	1,168,660					$	993,196					$	870,463
(1) Reflects revenue for service, maintenance and parts.

(In thousands)			2023						2022						2021
Segment operating income
Plasma			$	278,580					$	183,131					$	172,463
Blood Center			132,107						136,691						141,962
Hospital			154,416						129,783						84,066
Segment operating income			565,103						449,605						398,491
Corporate expenses (1)			(355,089)						(281,476)						(256,751)
Effect of exchange rates			8,419						18,993						12,830
Amortization of acquired intangible assets			(32,640)						(47,414)						(32,830)
Impairment of assets and PCS2 related charges			616						(5,732)						(25,696)
Integration and transaction costs			411						(21,604)						(18,421)
Restructuring and restructuring related costs			(11,549)						(28,824)						(15,661)
Digital transformation costs			(4,536)						—						—
MDR and IVDR costs			(9,854)						(11,033)						(4,130)
Litigation-related charges			(5,230)						(1,368)						(897)
Gains on divestitures and sale of assets			382						9,603						32,812
Operating income			$	156,033					$	80,750					$	89,747
(1) Reflects shared service expenses including quality and regulatory, customer and field service, research and development, manufacturing and supply chain, as well as other corporate support functions.

(In thousands)			2023						2022						2021
Depreciation and amortization
Plasma			$	41,612					$	28,314					$	24,093
Blood Center			13,927						32,489						39,672
Hospital			37,768						36,944						20,522
Total depreciation and amortization (excluding impairment charges)			$	93,307					$	97,747					$	84,287

(In thousands)			April 1, 2023						April 2, 2022
Long-lived assets(1)
Plasma			$	202,075					$	129,241
Blood Center			68,395						82,714
Hospital			40,415						46,527
Total long-lived assets			$	310,885					$	258,482
(1) Long-lived assets are comprised of property, plant and equipment.

Selected information by operating regions is presented below:

(In thousands)			April 1, 2023						April 2, 2022
Long-lived assets(1)
United States			$	251,812					$	200,927
Japan			997						1,096
Europe			14,587						11,989
Asia			26,263						28,132
Other			17,226						16,338
Total long-lived assets			$	310,885					$	258,482
(1) Long-lived assets are comprised of property, plant and equipment.

(In thousands)			2023						2022						2021
United States			$	842,897					$	639,322					$	522,607
Japan			61,295						75,562						77,676
Europe			156,680						163,520						159,077
Asia			104,135						110,802						105,820
Other			3,653						3,990						5,283
Net revenues			$	1,168,660					$	993,196					$	870,463

Schedule of Revenues by Product Line

Net revenues by product line are as follows:

(In thousands)			2023						2022						2021
Plasma products and services			563,734						427,611						414,266
Blood Center products and services			226,819						236,158						239,614
Hospital products and services			378,107						329,427						216,583
Net revenues			$	1,168,660					$	993,196					$	870,463

X

- Definition

Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

+ Details

Name:	us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

+ Details

Name:	us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration